Podiatry Claim Denials Are Rising: The Billing Patterns That Cost Practices the Most

Why Are Podiatry Claim Denials Increasing in 2026?

As of October 2026, claim denial rates across healthcare are shifting toward clinical denials, with prior authorization and medical necessity rejections driving a 25% increase in net revenue leakage according to Kodiak Solutions’ benchmarking data covering 2,400 hospitals and 375,000 physicians. Podiatry practices face elevated denial risk because routine foot care, diabetic shoe claims, and nail debridement services each carry specialty-specific documentation and modifier requirements that general billing workflows often miss.

Routine foot care denials lead in podiatry.
Claims for nail debridement and callus trimming require Q modifiers (Q7, Q8, Q9) and a documented systemic condition to establish medical necessity under Medicare.

Clinical denials now outpace administrative errors.
The industry-wide shift means that fixing NPI numbers and modifiers is no longer enough. Prior authorization and medical necessity documentation are driving the revenue loss.

Diabetic shoe claims face the highest scrutiny.
OIG audits and Medicare Administrative Contractor reviews have increased improper payment findings on DMEPOS claims billed by podiatry practices.

What the 2026 Denial Data Shows

Kodiak Solutions released its “State of the Healthcare Revenue Cycle” report in March 2026, covering more than 2,300 hospitals and 375,000 physicians. The headline finding: net revenue leakage from denials and uncollected balances grew 25% in 2025, reaching more than $48 billion. Clinical denial rates, covering denials for lack of prior authorization and disputes over medical necessity, accounted for nearly all of the increase.

A follow-up report published in September 2026, “Unyielding Denials,” showed initial denial rates declining to 10.63% in H1 2026 from 12% a year earlier. But the improvement is misleading. Payers are approving more claims initially and then recovering revenue through post-payment audits and clawbacks. For podiatry practices, this pattern is especially dangerous because routine foot care claims and diabetic shoe billing are among the most audited service categories in Medicare.

The most common issue we see providers run into is assuming their denial rate is acceptable because initial denials are down. What the data shows is that final denials and post-payment recoveries are where the revenue actually disappears. A podiatry practice that bills $800,000 annually and sees 10% initial denials loses roughly $80,000 in initially denied claims. If the practice recovers 70% through appeals, it still permanently loses $24,000 per year before accounting for the staff time spent reworking those claims.

Which Podiatry Claims Face the Highest Denial Risk?

Podiatry has denial patterns that are unique to the specialty. While the Kodiak data covers all specialties, the specific claim types that drive denials in podiatry are concentrated in three categories: routine foot care requiring Q modifiers, diabetic shoe and DME claims, and nail debridement bundled with E/M visits.

Claim Type	Primary Denial Reason	Prevention Strategy
Routine foot care (11720, 11721)	Missing or incorrect Q modifier (Q7, Q8, Q9)	Document systemic condition on every claim; apply correct Q modifier
Diabetic shoe program (A5500-A5513)	Missing certifying physician statement or annual exam	Obtain Statement of Certifying Physician before dispensing
Nail debridement + E/M same day	Modifier 25 not supported by documentation	Separate the E/M documentation from the procedure note
Wound debridement (97597/97598)	Medical necessity not established	Document wound measurements, depth, and clinical rationale
Custom orthotics (L3000 series)	Prior authorization not obtained or expired	Verify PA requirements by payer before fabrication

Sources: Kodiak Solutions 2026; CMS DMEPOS billing guidelines; Medicare Claims Processing Manual, Chapter 16 (routine foot care).

Across the billing companies we vet, the ones that handle podiatry effectively build the Q modifier documentation into the charge capture workflow so the modifier is applied before the claim leaves the office, not added after a denial comes back.

Steps to Reduce Podiatry Denials Now

The denial landscape has shifted. Here is the action plan for podiatry practices.

1. Audit your routine foot care claims for Q modifier accuracy. Pull the last 90 days of 11720 and 11721 claims and verify that every claim includes the correct Q modifier (Q7, Q8, or Q9) with a documented systemic condition that establishes medical necessity.
2. Verify your diabetic shoe documentation workflow. Every diabetic shoe claim requires a Statement of Certifying Physician, a comprehensive foot exam within the prior 12 months, and a prescription from the treating physician. Missing any one of these triggers a denial that cannot be appealed without the documentation.
3. Separate E/M documentation from procedure notes on same-day claims. When billing an E/M visit with modifier 25 alongside a nail debridement, the E/M note must document a separately identifiable evaluation beyond the procedure itself. A single note that combines both services without distinguishing the E/M component will be denied.
4. Track payer-specific prior authorization requirements for orthotics. Prior authorization rules for custom orthotics (L3000 series) vary by payer and by state. Build a PA verification step into your scheduling workflow for any orthotic fitting appointment.
5. Review wound care documentation for medical necessity depth. Wound debridement claims (97597, 97598) require documentation of wound size, depth, tissue type, and the clinical rationale for debridement. Notes that describe the procedure without establishing why it was medically necessary will not survive a payer review.
6. Monitor post-payment audit activity. Per the September 2026 Kodiak data, payers are increasingly approving claims initially and recouping through audits. Track any take-backs on DMEPOS claims and routine foot care services and appeal those that are not supported by the audit findings.

Mistakes That Drive Podiatry Denials

Providers often come to us after a spike in denials they cannot explain. In podiatry, the explanation is almost always one of the same three patterns.

The first is treating Q modifiers as optional. Medicare requires a Q7, Q8, or Q9 modifier on every routine foot care claim to indicate the systemic condition that makes the service medically necessary. Q7 indicates one Class A finding, Q8 indicates two Class B findings, and Q9 indicates one Class B finding plus two Class C findings, with all findings documented from the same foot. Submitting a nail debridement claim without the appropriate Q modifier results in an automatic denial that no amount of appeal work can overturn without the modifier and supporting documentation.

The second pattern is submitting diabetic shoe claims without the complete documentation chain. The certifying physician statement, the comprehensive foot exam, and the prescription must all be in place before the shoes are dispensed. Practices that dispense first and document later discover the gap only when the claim is denied, and by that point the shoes are already in the patient’s hands.

The third mistake is failing to update documentation templates when payer requirements change. One question we hear constantly from practice managers is why claims that were paid last year are now being denied. The answer is usually that the payer updated its medical necessity criteria, its prior authorization list, or its documentation requirements, and the practice’s templates did not change to match. A billing partner that tracks payer-specific podiatry requirements across Medicare, Medicaid, and commercial plans catches these changes before they become denial patterns.

In-House vs. Outsourced Denial Prevention

In our experience matching providers with billing partners, podiatry practices that handle billing in-house tend to have the highest denial rates on routine foot care and DMEPOS claims. The reason is not that in-house billers lack skill. It is that podiatry billing requires specialty-specific knowledge that general billing staff often do not have: Q modifier rules, diabetic shoe documentation chains, NCCI bundling rules for same-day nail debridement and E/M visits, and payer-specific orthotics prior authorization requirements.

A billing company that specializes in podiatry builds these requirements into its standard workflow. The Q modifier is applied at charge capture. The diabetic shoe documentation is verified before the claim is generated. The E/M and procedure notes are reviewed for modifier 25 compliance before submission. The result is a lower initial denial rate, fewer reworked claims, and less exposure to post-payment audits.

For practices billing under $500,000 annually, the cost of a single denied diabetic shoe claim ($200 to $400 depending on the product) plus the staff time to rework it often exceeds the incremental cost of outsourcing to a billing partner with podiatry expertise. For larger practices, the compound effect of preventing 5 to 10 routine foot care denials per week translates directly to recovered revenue that the practice would otherwise write off. If your current billing process is generating a pattern of Q modifier denials or DMEPOS rejections, the process itself may need to change.

Frequently Asked Questions

Next Steps

Start by auditing your routine foot care claims for Q modifier accuracy and pulling denial reports for the last 90 days. If diabetic shoe or DMEPOS denials are a recurring pattern, review your documentation workflow against the DMEPOS compliance requirements. For a quick reference on podiatry billing codes and modifier rules, see our podiatry billing cheat sheet.